ADEZA BIOMEDICAL CORP

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Tender offer statement by a third party (amendment)

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Notification of removal from listing and/or registration on a national securities exchange

Certification of termination of registration of a class of securities (Section 12(g))

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Tender offer statement by a third party (amendment)

Changes in Control of Registrant

Tender offer statement by a third party (amendment)

Annual report pursuant to Section 13 or 15(d)

Tender offer statement by a third party (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

No description available

Tender offer statement by a third party

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

1.01,9.01

No description available

1.01,5.02

5.02

Entry into a Material Definitive Agreement

General form for quarterly reports under Section 13 or 15(d)

2.02,8.01,9.01

1.01

3.01

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

General form for quarterly reports under Section 13 or 15(d)

2.02,8.01,9.01

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d) (amendment)

Annual report pursuant to Section 13 or 15(d)

2.02,5.02,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

1.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

1.01,9.01

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

2.02,5.02,9.01

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Amended Initial Registration Statement

Correspondence with the SEC

Correspondence with the SEC

Amended Initial Registration Statement

No description available

Correspondence with the SEC

Correspondence with the SEC

Amended Initial Registration Statement

Letter from the SEC

Letter from the SEC

Amended Initial Registration Statement

Letter from the SEC

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Withdrawal of a registration statement

Amended Initial Registration Statement

Amended Initial Registration Statement

Registration of Securities on Exchange (amendment)

No description available

Registration (IPO) statement under Securities Act of 1933

No description available

Augusta Medical CORP

Augusta Medical CORP

Kingsley Stuart A

SULLIVAN PATRICK J

MCDONOUGH JOHN P

Adams Timothy M